BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/25/2025 7:54:09 AM | Browse: 2 | Download: 0
 |
Received |
|
2025-01-27 07:06 |
|
Peer-Review Started |
|
2025-01-27 07:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-02-25 08:31 |
|
Revised |
|
2025-03-03 13:05 |
|
Second Decision |
|
2025-03-20 10:02 |
|
Accepted by Journal Editor-in-Chief |
|
2025-03-22 04:22 |
|
Accepted by Executive Editor-in-Chief |
|
2025-03-24 05:23 |
|
Articles in Press |
|
2025-03-24 05:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2025-03-26 04:33 |
|
Typeset the Manuscript |
|
2025-04-08 08:27 |
|
Publish the Manuscript Online |
|
2025-04-25 07:54 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Anemia risk and mitigation strategies in type 2 diabetic patients: The role of novel antidiabetic agents
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Petra Meliš and Maja Cigrovski Berkovic |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maja Cigrovski Berkovic, Associate Professor, MD, PhD, Department for Sport and Exercise Medicine, University of Zagreb Faculty of Kinesiology, Horvacanski zavoj 15, Zagreb 10000, Croatia. maja.cigrovskiberkovic@gmail.com |
| Key Words |
Anemia; Type 2 diabetes mellitus; Chronic kidney disease; Iron deficiency; Metformin; SGLT-2i; Glucagon-like peptide-1 receptor agonist; Glucagon-like peptide-1 receptor agonist/GIP dual agonists |
| Core Tip |
This review focuses on the overlooked prevalence and effect of anemia in type 2 diabetes, particularly in the context of chronic kidney disease. It focuses on the complicated interplay between anemia, glucose management, and diabetes-related comorbidities, as well as the possibility of emerging antidiabetic medications (SGLT2 inhibitors and glucagon-like peptide-1 receptor agonists) to reduce anemia risk. Furthermore, the study underlines the significance of early identification of anemia and the benefits of newer antidiabetic drugs in terms of cardiovascular and kidney outcomes. |
| Publish Date |
2025-04-25 07:54 |
| Citation |
<p>Meliš P, Cigrovski Berkovic M. Anemia risk and mitigation strategies in type 2 diabetic patients: The role of novel antidiabetic agents. <i>World J Diabetes</i> 2025; 16(5): 105549</p> |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i5/105549.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i5.105549 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
